Medpace Holdings, Inc. MEDP Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medpace Holdings, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medpace Holdings, Inc.'s cash & equivalents?
- Medpace Holdings, Inc. (MEDP) reported cash & equivalents of $652.68M in Q1 2026.
- How has Medpace Holdings, Inc.'s cash & equivalents changed year-over-year?
- Medpace Holdings, Inc.'s cash & equivalents increased by 47.9% year-over-year, from $441.44M to $652.68M.
- What is the long-term trend for Medpace Holdings, Inc.'s cash & equivalents?
- Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s cash & equivalents has grown at a 12.3% compound annual growth rate (CAGR), from $277.77M to $497.05M.
- What does cash & equivalents mean?
- The total amount of cash and highly liquid investments the company has on hand.
- How do you interpret cash & equivalents?
- An increase suggests strong liquidity and potential for future investment, while a decrease may indicate heavy capital expenditure or cash burn.
- How does cash & equivalents compare across companies?
- Standard across all industries; peers typically maintain sufficient levels to cover short-term operational needs.